KLAS Contact
Contact KLAS
Contact KLAS
2022 BEST IN KLAS
Preferences
Related Series
2020
2018
2017
2015
2013
2012
2011
2011
2010
2009
2008
2008
2007
2007
2006
2006
2006
2005
2005
2005
Related Segments
Related Products
Related Vendors
Community Hospital PACS 2008
Current Time Inside Cache Tag Helper: 5/28/2022 1:32:48 AM and Model.reportId = 499
KLAS monitors two dozen vendors that target the community hospital space as a growth market, and 17 of those vendors are profiled in this report.With so many choices, healthcare provider organizations have a number of questions they want answered. How do the larger, established imaging vendors that originated in the large hospital market perform in the community hospital space? How do these vendors compare to vendors that originated in the ambulatory or small hospital market? As long-term imaging and enterprise strategies are considered, which vendors are experiencing robust growth and which ones are losing business? Which vendors consistently deliver?
Products qualifying for ranking in the study were (in alphabetical order):
- AMICAS Vision Series
- Agfa IMPAX
- Aspyra AccessNET
- Avreo interWORKS interview
- BRIT Systems BRIT Roentgen Files
- Carestream PACS
- DR Systems Unity
- FUJIFILM Synapse
- GE Centricity IW
- Infinitt PACS
- McKesson Horizon Medical Imaging
- Merge Healthcare Fusion PACS MX
- NovaRad NovaPACS
- Philips iSite
- Sectra PACS
- Siemens syngo Imaging
- eRAD PACS
Early findings were also included for Cerner Millennium ProVision, Emageon Enterprise Visual, GE Centricity, Intelerad IntelePACS, OpenMed PACS, RAYPAX PACS, and ScImage PicomEnterprise Radiology.
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2022 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.